Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Berlin - Delayed Quote EUR

Halozyme Therapeutics Inc (RV7.BE)

Compare
52.12
-1.28
(-2.40%)
At close: April 17 at 8:08:20 AM GMT+2
Loading Chart for RV7.BE
  • Previous Close 53.40
  • Open 52.12
  • Bid 51.54 x --
  • Ask 51.84 x --
  • Day's Range 52.12 - 52.12
  • 52 Week Range 35.80 - 60.26
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 5, 2025 - May 9, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: RV7.BE

View More

Performance Overview: RV7.BE

Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

RV7.BE
13.53%
S&P 500 (^GSPC)
10.18%

1-Year Return

RV7.BE
44.82%
S&P 500 (^GSPC)
5.19%

3-Year Return

RV7.BE
37.57%
S&P 500 (^GSPC)
20.26%

5-Year Return

RV7.BE
196.14%
S&P 500 (^GSPC)
83.77%

Compare To: RV7.BE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: RV7.BE

View More

Valuation Measures

Annual
As of 4/17/2025
  • Market Cap

    6.37B

  • Enterprise Value

    7.17B

  • Trailing P/E

    17.32

  • Forward P/E

    12.82

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    7.57

  • Price/Book (mrq)

    20.17

  • Enterprise Value/Revenue

    8.05

  • Enterprise Value/EBITDA

    12.45

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: RV7.BE

View More

Company Insights: RV7.BE

Research Reports: RV7.BE

View More